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Abstract
Introduction. In the prevention of ischaemic stroke the recommended surgical procedure is carotid endarter-
ectomy (CEA). However, surgical treatment of atherosclerotic stenosis may cause neurological complications. 
The aim of the study was to investigate consequential brain ischaemia-reperfusion injury by measuring the 
cerebral specific markers, the microtubule associated protein tau (MAPt) and myelin basic protein (MBP) in 
the serum of patients that underwent CEA.
Material and methods. This study involved 25 participants who underwent CEA due to internal carotid 
artery stenosis. Blood samples were taken from each patient at three different intervals; within 24 hours prior to 
surgery, 12 hours after the surgery, and 48 hours after the surgery. Serum MAPt and MBP levels were measured 
by a commercially available enzyme-linked immunosorbent assay (ELISA).
Results. The study showed that serum MAPt and MBP levels were statistically significantly decreased 12 hours 
after CEA compared to the level before the surgery (p < 0.05), but MAPt and MBP levels were normalized 
48 hours after CEA. There was statistically significant correlation in serum MAPt levels with the velocity of blood 
flow in the internal carotid artery 12 and 48 hours after CEA (p < 0.05).
Conclusions. Data from our study showed that CEA affects serum neuromarkers levels, such as MAPt and 
MBP, in patients with significant internal carotid artery stenosis. MAPt and MBP levels showed characteristic 
time curve in patients who underwent CEA and did not experience any neurological deficit in perioperative 
period. Possible alterations of this time curve may potentially be an index of a neurological event occurrence.
Key words: carotid endarterectomy, microtubule associated protein tau, myelin basic protein, 
neuromarkers, serum
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Introduction
Stroke, of which most cases are ischaemic, is a major 
source of morbidity in patients. Various therapeutic 
strategies may improve the prognosis, reduce mortality 
of patients and costs of their hospitalization [1].
Carotid endarterectomy (CEA) is widely accepted 
surgical treatment of the chronic brain ischaemia caused 
by haemodynamically significant stenosis of internal 
carotid artery [2]. However, surgical treatment of 
atherosclerotic stenosis may cause neurological com-
plications during the perioperative period. These com-
plications include micro and macro embolism resulting 
in ischaemic brain injury. Moreover, acute ischaemia and 
reperfusion by clamping and declamping of the internal 
carotid artery during CEA may produce oxygen-derived 
free radicals resulting in impairment of cerebrovascular 
autoregulation, postischaemic hyperperfusion, and 
brain oedema [3–6].
The microtubule associated protein tau (MAPt) gene 
encodes the soluble tau protein. This protein is found 
in abundant quantities in the central nervous system, 
and subsequently functions to assemble and stabilize 
microtubules in order to maintain the cytoskeletal 
structure [7]. As a result of alternative splicing of the 
MAPt transcripts, six specific isoforms of the tau pro-
teins are generated. They range in size from 352 to 441 
amino acid residues in length and are expressed in the 
human brain [8]. Data from the literature showed that 
tau protein may be a marker of brain damage in different 
neurological diseases, such as stroke, traumatic brain 
injury, Creutzfeldt-Jakob disease, Parkinson disease, 
and amyotrophic lateral sclerosis [9–13].
Myelin basic protein (MBP), a constituent of the 
myelin sheath, is essential for normal myelination and 
conduction of axonal signal. This protein mediates 
adhesion between cytoplasmic surfaces of individual 
myelin layers [14]. MBP is located within the serous 
surface of myelin sheath, where it gets integrated with 
the myelin lipids. MBP was proved to stabilize the 
structural properties of myelin and thus influencing 
its function in central nervous system. MBP is nervous 
tissue specific, and this protein may reflect the severity 
of myelin and central nervous system damage [15]. MBP 
was described as marker of brain injury in neurological 
conditions, such as cerebral ischaemia, traumatic brain 
injury, and multiple sclerosis [16–19].
Therefore, MAPt and MBP could also be neuro-
chemical markers of brain ischaemia-reperfusion injury 
in patients undergoing CEA. 
The aim of the present investigation was to assess 
serum MAPt and MBP levels and their dynamics in time 
in patients who underwent CEA.
Material and methods
The study involved patients hospitalized in the De-
partment of Vascular Surgery and Angiology, Medical 
University of Lublin, Poland, undergoing CEA due to 
stenosis of the internal carotid artery. 
Patients were qualified for surgical treatment according 
to the guidelines of the European Society of Vascular Sur-
gery based on Doppler studies performed using a Toshiba 
Aplio 500 ultrasound [20]. Patients with high grade stenotic 
carotid arteries were identified and measured using the 
guidelines set forth by NASCET (North American Symp-
tomatic Carotid Endarterectomy Trial) [21].
The study group consisted of 25 participants 
(15 male, 10 female) aged from 54 to 88 years with 
an average of 69 years. Patients with the occlusion of 
the internal carotid artery were not qualified for sur-
gery and research. The degree of the internal carotid 
artery stenosis ranged from 60 to 90%. The average 
clamping time of internal carotid artery during CEA was 
8.5 minutes. Conventional CEA was performed under 
local anaesthesia. Shunt was not used. No complications 
associated with CEA were observed. The average 
velocity of blood flow in the internal carotid artery 
before surgery was 208.4 cm/s, and after the surgery — 
89.5 cm/s. In the postoperative period neurological state 
was monitored by a neurologist. Neurological state af-
ter CEA, in all patients participating in the study, did not 
differ from the neurological state before surgery. Past 
medical histories of the subjects included symptomatic 
patients; 8 patients with previous ischaemic stroke, 
7 patients with transient ischaemic attack, and 10 patients 
with asymptomatic internal carotid artery stenosis. 
Blood samples were taken from each patient from 
the antecubital vein at the following time points: within 
24 hours prior to surgery (measurement 1), 12 hours 
after surgery (measurement 2), and 48 hours after 
surgery (measurement 3). Samples of serum were 
collected and centrifuged immediately, then stored at 
–80 Celsius degrees to the time of analysis.
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Serum MAPt and MBP levels were measured by 
a commercially available enzyme-linked immunosorbent 
assay (Enzyme-linked Immunosorbent Assay Kit for 
Microtubule Associated Protein Tau (MAPt) and En-
zyme-linked Immunosorbent Assay Kit for Myelin Basic 
Protein (MBP); Cloud Clone Corp./USCN, Houston, 
TX, USA).
Both commercially available enzyme-linked im-
munosorbent assay (ELISA) systems were performed 
according to the instructions of the manufacturer. 
Statistical analysis was performed using STATISTI-
CA, version 12 software (StatSoft, Inc., Poland). The 
data were not normally distributed and therefore the 
nonparametric Wilcoxon, Mann-Whitney and Friedman 
tests were used to measure the differences between 
variables. The association between variables was tested 
using Spearman’s rank correlation coefficient. The MAPt 
levels were measured in pg/mL, and the MBP levels are 
expressed in ng/ml (median and range). The level of 
statistical significance was p < 0.05. 
The study was approved by the Ethics Committee 
of Medical University in Lublin (KE-0254/218/2014) and 
was conducted according to Declaration of Helsinki 
given by World Medical Association. All participants 
signed an informed consent before entering the study.
Results
The study showed that serum MAPt level was 
statistically significantly decreased 12 hours after CEA 
compared to level before surgery (p < 0.05), and MAPt 
level was normalized 48 hours after CEA. The serum 
MAPt levels and a comparative analysis are presented 
in Table 1 and in Figure 1. 
Analysis of variance showed that the sampling time 
does not significantly affect MAPt levels in the serum 
(p = 0.08). 
There was no statistical significant difference in 
serum MAPt levels between symptomatic and asymp-
tomatic patients (p > 0.05).
Additionally, there was no statistically significant 
correlation between serum MAPt level and age of 
patients (p = 0.88).
There was no statistically significant correlation in 
serum MAPt level 12 and 48 hours after surgery with 
the clamping time (r = –0.07, p = 0.72 and r = –0.36, 
p = 0.07; respectively).
There was also no statistically significant correlation 
in the serum MAPt levels with the velocity of blood flow 
in the internal carotid artery before CEA (r = 0.09, 
p = 0.65). However, 12 and 48 hours after surgery 
the correlation was statistically significant (r = 0.58, 
p = 0.002 and r = 0.53, p = 0.006; respectively).
Table 1. Serum MAPt and MBP levels, and a comparative analysis
Measurement MAPt level [pg/mL] MBP level [ng/mL]
Before surgery — 1 2.97 (0.31–36.82) 0.21 (0.03–0.50)
12 hours after surgery — 2 2.09 (0.57–25.64) 0.14 (0.02–0.38)
48 hours after surgery — 3 2.83 (0.44–28.16) 0.23 (0.03–0.37)
Comparison
1–2 p = 0.022* p = 0.001*
2–3 p = 0.017* p = 0.024*
1–3 p = 0.716 p = 0.39
Data are expressed as median and range; Wilcoxon test; p* — statistically significant
Figure 1. Serum microtubule associated protein tau in patients
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The study showed that serum MBP level was statis-
tically significantly decreased 12 hours after CEA com-
pared with level before surgery (p < 0.05), and MBP 
level was normalized 48 hours after CEA. The serum 
MBP levels and a comparative analysis are presented 
in Table 1 and in Figure 2.
The analysis of variance showed that there were 
statistically significant differences in serum MBP levels 
between all three recorded measurements (p = 0.0038).
There was no statistical significant difference in 
serum MBP levels between symptomatic and asymp-
tomatic patients (p > 0.05).
There was no statistically significant correlation be-
tween serum MBP level and age of patients (p = 0.07).
There was no statistically significant correlation in 
serum MBP level 12 and 48 hours after the surgery with 
the clamping time (r = –0.11, p = 0.59 and r = –0.09, 
p = 0.64; respectively).
There was also no significant correlation in the se-
rum MBP levels with the velocity of blood flow in the 
internal carotid artery before CEA (r = 0.14, p = 0.47) 
and after surgery (r = 0.04, p = 0.83 and r = 0.25, 
p = 0.22; respectively).
There were no statistically significant correlations 
between serum MAPt and MBP levels in all three 
measurements (p = 0.13, p = 0.67, and p = 0.77; 
respectively).
Discussion
CEA may cause ischaemic-hyperperfusion brain 
injury. According to Komoribayashi et al. [22] hyperper-
fusion syndrome after CEA is directly related to preop-
erative and additive, intraoperative ischaemia evoked 
by clamping of common carotid artery during surgery. 
Transient brain ischaemia — also occurring during 
CEA — may induce hyperphosphorylation of MAPt. 
The results of the study conducted by Song et al. [23] 
confirmed that tau protein is dephosphorylated during 
brain ischaemia. However, after reperfusion, this pro-
tein is hyperphosphorylated. Thus, the theory above 
may play an important role in the evolution of brain 
damage after brain ischaemia. Zheng et al. [24] hypoth-
esize that the alterations in phosphorylation of tau are 
important for metabolism and microtubule dynamics, 
and contribute to the pathophysiology of brain ischae-
mia and/or reperfusion. Wen et al. [25] suggested that 
tau hyperphosphorylation can cause neurological injury 
in the mechanism related to transient brain ischaemia, 
and may play important role in the pathophysiology of 
neurodegeneration after ischaemic stroke. 
The effects of cerebral ischaemia and reperfusion 
on phosphorylation of MAPt were measured in a canine 
model of cardiac arrest. The study conducted by Mailliot 
et al. [26] reports a complete dephosphorylation of 
tau proteins during ischaemia. The authors concluded, 
that monitoring of the recovery of tau phosphorylation, 
which is a sequential and differential process after is-
chaemia-reperfusion syndrome, may be an important 
marker in the assessment of the neuronal integrity after 
brain ischaemia. 
According to Bitsch et al. [27], serum tau protein 
was detectable within 5 days after ischaemic stroke in 
7/20 patients and in 2/10 patients with transient ischae-
mic attack. Tau protein was detectable within the 6h 
after occurrence of symptoms, reaching the peak level 
after 3–5 days and correlated with infarct volume as well 
as the grade of disability evaluated 3 months after the 
event. The authors concluded that serum tau protein 
may be a marker of axonal injury. Wunderlich et al. [28] 
observed that in patients with ischaemic stroke, serum 
tau protein levels were increased and correlated with 
severity of neurological state of patients, infarct volume, 
and with the functional outcome after 3 months. 
Experimental investigation conducted on rats, 
demonstrated that myelin sheath is generally very vul-
nerable to ischaemia. The MBP mRNA levels decreased 
2 days after ischaemia, and continued to decrease, what 
was observed at each measurement at four points in 
Figure 2. Serum myelin basic protein in patients
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time. The MBP levels significantly decreased at the 
2nd and 4th day, but at day 7 recovery was observed, 
reaching the control levels at day 14 [29]. This finding 
is with agreement of Chen et al. study, who found that 
the consequences of the ischaemia on cerebral white 
matter are time sensitive, however there was no typical 
scenario over the time. Chida et al. [30] investigated 
the alterations in oligodendrocytes and myelin following 
chronic cerebral ischaemia in rats and observed that 
the amount of MBP was decreased significantly. Cai et 
al. [31] demonstrated a rat model of chronic cerebral 
hypoperfusion. On the 30th day after ischaemia, white 
matter oligodendrocytes presented more severe loss 
and myelin disruption than in control group. The study 
conducted by other authors showed that hypoxia/ 
/ischaemia induces serious hypomyelination [32]. Fan et 
al. [33] observed after bilateral carotid artery occlusion 
and hypoxic insult resulted in brain injury with impaired 
myelination and decreased MBP immunostaining in 
the rat brain. The authors concluded that the degree 
of brain injury is dependent on the hypoxic/ischaemic 
condition, including the exposure time to hypoxia. 
Ischaemic injury to the brain, leads to cellular ac-
tivation and disintegration with subsequent release of 
cell-type-specific proteins into the cerebrospinal fluid 
(CSF), including MBP, Brouns et al. [34]. The authors 
observed that CSF MBP level was significantly higher in 
patients with subcortical infarcts compared with those 
with cortical infarcts, and concluded that this protein 
may also be a marker for infarct location. Hjalmarsson 
et al. [35] revealed significantly higher levels of protein 
tau and MBP in CSF of patients with ischaemic stroke 
which correlated with clinical severity of the stroke.
There are no studies in the literature concerning 
serum MAPt and MBP levels after CEA. Our study 
showed that serum MAPt and MBP levels were sig-
nificantly decreased 12 hours after CEA compared to 
level before surgery, and that these serum biomarkers 
normalized 48 hours after CEA. Similar results were ob-
served in study conducted by Rasmussen et al. [36]. The 
authors measured serum levels of another marker of 
brain injury, neuron-specific enolase (NSE), in patients 
before CEA and postoperatively at 12, 24, 36, and 48 
hours. Postoperatively, the serum NSE level decreased 
significantly after uncomplicated CEA. Brightwell et al. 
[37] hypothesize that a significant internal carotid artery 
stenosis may cause an increased background level of 
NSE release. After CEA brain perfusion gets normalised 
and levels of NSE subsequently fall with time. 
It is difficult to say why MAPt and MBP levels were 
higher before CEA in our study. Perhaps this is a result 
of brain damage caused by chronic ischaemia due to a 
significant stenosis of the internal carotid artery. It can 
be hypothesized that a significant decrease in the levels 
of serum MAPt and MBP in the early period after CEA 
may be associated with improved blood supply to the 
brain while normalization of these markers may be 
result of ischaemic-hyperperfusion brain damage at 
a later date after surgery. 
The results of the study conducted by Céspedes et al. 
[38] suggest that in ischaemic rat models, the immu-
noreactivity of the hyperphosphorylated tau protein 
marker (AT-8) steadily increased until 72 hours after 
ischaemia. This finding suggests that the progression of 
excitotoxicity and resultant alteration of enzymes was 
involved in phosphorylation of cytoskeletal proteins. 
Progressing brain damage caused by ischaemia-hyper-
perfusion associated with the CEA procedure, could 
therefore explain the observation in our study of the 
increased serum MAPt and MBP levels between 12 and 
48 hours after surgery.
In our study, we observed similar dynamics of MAPt 
and MBP changes in serum of patients. Seiberlich et al. 
[39] showed that tau knockdown may affect overpro-
duction and leads to a decreased expression of MBP. The 
authors concluded that disturbances in the metabolism 
of tau protein may cause abnormal oligodendrocyte 
differentiation, neuron-glia adhesion and the early 
processes of myelination. Similar dynamics of serum 
MAPt and MBP changes observed during our study may 
reflect this process.
Data from our study showed that there was sta-
tistically significant correlation in serum MAPt levels 
with the velocity of blood flow in the internal carotid 
artery 12 and 48 hours after CEA. An increase in serum 
MAPt levels in association with higher blood flow may 
be caused by cerebral hyperperfusion. In our opinion, 
after CEA, when stenosis is already absent, higher 
velocity of blood flow probably correlates with blood 
flow higher value.
The study revealed the lack of difference in serum 
MAPt and MBP levels between symptomatic and asymp-
tomatic patients. Such a division of the patients have 
been due to the patients’ medical histories. However, 
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on the day of the surgery and blood sampling, all pa-
tients were asymptomatic, which explains the result.
Our study evaluated the effect of endarterectomy on 
the levels of MAPt and MBP in serum, the level before the 
surgery was a control. The surgery was effective because 
the levels of the tested parameters declined significantly 
immediately after endarterectomy. In our opinion, the 
recovery levels of these markers observed 48 hours after 
surgery, does not reflect the lack of effectiveness of the 
surgery, but it could be the expression of neurological 
complications associated with this surgical procedure, 
such as brain ischaemia/hyperperfusion syndrome, as 
discussed in the manuscript. As a result of ischaemia/ 
/hyperperfusion syndrome-associated endarterectomy 
damage may occur to the blood-brain barrier moving 
MAPt and MBP in the blood which increases their levels. 
Various concentrations of MAPt and MBP in serum of 
individual patients after surgery may indicate varying 
degrees of ischaemia/hyperperfusion syndrome, and the 
various levels of these markers before surgery can be an 
exponent of the degree of carotid stenosis and severity 
of chronic brain ischaemia.
Conclusions
Data from our study showed that CEA affects serum 
neuromarkers levels, such as MAPt and MBP, in patients 
with significant internal carotid artery stenosis. MAPt 
and MBP levels showed characteristic time curve in 
patients who underwent CEA and did not experience 
any neurological deficit in perioperative period. Possible 
alterations of this time curve may potentially be an index 
of a neurological event occurrence.
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